Divalproex Sodium Capsule, Delayed Release
Product Images NDC 72603-260

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 72603-260). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Container (Container)

Container (Container)
This is a description of Divalproex Sodium delayed-release capsules, each containing Valproic Acid activity. The medication guide should be provided to each patient separately by the pharmacist. The capsules are light blue-transparent with imprint "THIS END UP" on the cap and "RDY 532" on the body. They can be swallowed whole or opened for administration. Storage temperature is recommended at 20° to 25°C. For prescribing information, refer to the enclosed guide or visit the website or call the provided contact number. The capsules should be dispensed in a light-resistant container. The manufacturer is Northstar Rx LLC in Memphis, Tennessee, and the product is from Dr. Reddy's Laboratories Limited in India.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
FDA Label Image

Picture1 (Picture1)

Picture1 (Picture1)
FDA Label Image

Picture2 (Picture2)

Picture2 (Picture2)
FDA Label Image

Picture3 (Picture3)

Picture3 (Picture3)
FDA Label Image

Picture4 (Picture4)

Picture4 (Picture4)
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.